ELEV - Elevation Oncology Quarterly EPS earnings growth

Official company branding of Elevation Oncology, Inc. (ELEV)

Elevation Oncology relies on the monopolization of niche segments through targeted therapy, as evidenced by the quarterly net income per share growth rates on GURU.Markets. The -6.40 level reflects the current magnitude of this metric, which depends on the selectivity of NRG1 mutation treatments. Business development is based on scarce demand in precision oncology and new R&D partnerships with industry behemoths.

Elevation Oncology (ELEV) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 08/02/2025

Analytical breakdowns for Elevation Oncology

- market value and analyst target forecast:
Fundamental valuation:Elevation Oncology Inc. - ELEV
Flagship merchandise of elevationoncology.com

The specific nature of the oncology biotech firm Elevation Oncology (ELEV) makes the business independent of market cycles, shifting the focus toward clinical trial results. Relative quarterly EPS dynamics reflect the rate of change in net income per share, allowing investors to assess the efficiency of capitalizing on scientific achievements and avoid overpaying during sharp spikes or the risk of a drawdown when earnings decline.

Competitor analysis

ONC: Quarterly EPS earnings growth|Halozyme Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (Revolution Medicines Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Group AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth UroGen Pharma Ltd (URGN)|Quarterly EPS earnings growth BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth in annualized terms for the last twelve months|Erasca Oncology - Quarterly EPS earnings growth|DCTH: Year-over-year earnings per share growth for the last twelve months|YMAB: Quarterly EPS earnings growth|Aura Bio (AURA) - Quarterly EPS earnings growth|CADL (Candel Therapeutics Inc.) - Quarterly EPS earnings growth|ARAY: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SLS (SELLAS Life Sciences Group, Inc.)|Year-over-year earnings per share growth rate for the last twelve months ACTU|Citius Oncology - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HURA|TARA: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Fate Pharma|Aadi Bioscience Inc (WHWK) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months TScan (TCRX)|Year-over-year net earnings per share growth for the last 12 months CSBR|xbiotech.com (XBIT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months cel-sci.com (CVM)|OSTX - Earnings per share growth in annualized terms for the last twelve months|Radiopharm Theranostics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ARTV|ANL - Year-over-year earnings per share growth for the last twelve months|VERU - Quarterly EPS earnings growth|Tempest Therapeutics, Inc. (TPST) - Year-over-year earnings per share growth for the last twelve months|XLO: Year-over-year earnings per share growth rate for the last twelve months|RENB (Renovaro Biosciences) - Quarterly EPS earnings growth|MURA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KAPA (Kairos Pharma Ltd)|Year-over-year earnings per share growth rate for the last twelve months OKUR|CytoMed Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CRIS: Year-over-year earnings per share growth for the last 12 months|APLM - Year-over-year earnings per share growth for the last twelve months|THAR - Quarterly EPS earnings growth|ADVB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SBFM|Quarterly EPS earnings growth XBIO|Year-over-year net earnings per share growth for the last 12 months Salarius Pharmaceuticals SLRX|Quarterly EPS earnings growth PPBT (Purple Biotech Ltd)|AONC - Year-over-year net earnings per share growth for the last 12 months|BGNE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Checkpoint Therapeutics, Inc CKPT|ICAD: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Viracta Therapeutics (VIRX)|Year-over-year earnings per share growth for the last twelve months MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AAPGV (Ascentage)